A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement Therapy
Friedemann Taut(Altana (Germany)), Roger G. Spragg(University of California San Diego Medical Center), James F. Lewis(Western University), Gerd Rippin(Omnicare Pharma (Germany)), W Wurst, Dietrich Häfner(Altana (Germany)), Andreas Günther(Cardio-Pulmonary Institute), Peter Schenk, George Findlay(University Hospital of Wales), Werner Seeger(Justus-Liebig-Universität Gießen)
Cited by 98
Related Papers
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Pulmonary hypertension in chronic lung disease and hypoxia
|European Respiratory Journal|2018|777
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
|The Lancet|2002|771
Pulmonary Hypertension in Chronic Lung Diseases
|Journal of the American College of Cardiology|2013|683